Newsletter December 2013

Latest news from NeoventaNewsletter December 2013
Subscribe to Neoventa Newsletter

Read more

Neoventa and CSAM to develop integrated fetal monitor solution for enhanced patient safety within Obstetric Care.

Neoventa Medical AB has signed an agreement with Norwegian company CSAM Health AS to integrate the Neoventa Stan Viewer and Stan Viewer Live products with CSAM Partus, an electronic application for gynaecologists, midwives and paediatricians. The integration will make it possible for hospital staff, during birth and in pre-labour examinations, to view archived and real-time Stan tracings through their CSAM Partus Maternity Information System.
The Stan fetal monitor enables evidence-based ST Analysis of the fetal ECG as an adjunct …

Read more

A nationwide descriptive study of obstetric claims for compensation in Norway.

“Increased training in fetal monitoring and obstetric emergency situations are recommended to decrease the obstetric compensation claims”
In this article reasons for substandard care in obstetric compensation claims are discussed.
Fetal asphyxia is the most common reason for compensation, resulting in large financial expenses to society. Human errors contribute to inadequate health care in 92 % of obstetric compensation claims, although underlying system errors may also be present.
Fetal birth asphyxia, anal sphincter tear and infection are the most common …

Read more

Understanding cardiotocographic patterns associated with intrapartum fetal hypoxia and neurological injury

“If there are more focus on pattern recognition and pathophysiology it all becomes more evident.”
Obstetricians and midwives have been trained to focus on morphological appearances of fetal decelerations rather than to understand the underlying psychological mechanisms, how the fetus compensates and defends itself. In that way original interpretations of fetal heart patterns equated decelerations to fetal distress and mandated operative interventions. Since then consequently operative interventions are undertaken to rescue fetuses that display benign signs of fetal heart rate …

Read more

Customer Success Story: University Hospital in Tours, France

Using Stan, Feedback from the Obstetrical team of University Hospital in Tours.
Stan S31 is a fetal monitoring device which analyses the baby’s electrocardio­gram during labour and delivery. In the University Hospital of Tours (France) the Department of Obstetrics and Gynecology decided to expand the use of this device. Prof. Franck Perrotin, Head of Department, outlines why the institution has taken this decision.
Unlike conventional cardiotocographs usually used during delivery, Stan S31 not only analyses fetal heart rate, but also …

Read more

Poster at ECIC: Assessement of an e-Learning program of FHR monitoring. A randomised study

A French study shows that training in CTG interpretation using an e-learning program improves the performance of obstetrical staff.  A poster of this study was presented at the European Congress on Intrapartum Care (ECIC) in Amsterdam this spring.
 

Read more

Newsletter September 2013

Latest news from NeoventaNewsletter September 2013
Subscribe to Neoventa Newsletter

Read more

M.Sc thesis from Chalmers University in Sweden explores diffusion of the STAN-method in the fetal monitoring industry.

In June 2013, two students from the M.Sc programme “Management and Economics of Innovation” at Chalmers University of Technology presented their M.Sc thesis focusing on the fetal monitoring industry and STAN in particular. Their research study analyzes diffusion of STAN in Europe and utilizes the most cutting-edge theory and research methods at hand within the discipline of industrial management on the conditions for diffusion. During the study over 25 interviews were conducted with clinical professionals in 4 European countries, investigating …

Read more

Meta-Analysis shows significant improvements with ST-analysis

The March 2013 American Journal of Obstetrics and Gynecology (AJOG) included a publication by Schuit et al. entitled “Effectiveness of electronic fetal monitoring with additional ST analysis in vertex singleton pregnancies at >36 weeks of gestation: an individual participant data meta-analysis (MA).” Since the publication of the AJOG article, there have been two Letters to Editor, one from Prof. Rosen and a response from the authors, regarding issues with this particular MA. We encourage you to read these letters (on-line) …

Read more

Renewed meta-analysis: Further support for ST Analysis

The objective of this meta-analysis was to investigate the additional effect of ST Analysis as an adjunct to electronic fetal monitoring. In order to overcome the shortcomings of conventional meta-analysis that uses aggregated data, the present analysis used individual participant data to allow for a more thorough investigation by taking all information into account, including accounting for missing data.
Only four of the five published randomised controlled trials (RCT) were included in the analysis. The first RCT by Westgate …

Read more
Page 5 of 10 «...34567...»

# #